Chadi Nabhan, MD, MBA, FACP

Chadhi Nabhan, MD, MBA, FACP, is a hematologist/oncologist and award-winning host of the “Outspoken Oncology” and “Healthcare Unfiltered” podcasts.

Articles by Chadi Nabhan, MD, MBA, FACP

Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | November 16, 2023
We saw patients [who] were going to die, and it saved their life and then it's gone and it's shocking," she explained.
Listen Now
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | November 2, 2023
Dr. Cortes chats about the “boom” in treatments for chronic myeloid leukemia (CML), and where he sees a need for balance.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | October 19, 2023
Elias Jabbour, MD, discusses the most burning questions in acute lymphoblastic leukemia (ALL).
Chadi Nabhan, MD, MBA, FACPMyeloma | October 5, 2023
Dr. Fonseca offers his thoughts on the future of multiple myeloma treatment and more.
Chadi Nabhan, MD, MBA, FACPMeeting News | September 14, 2023
Dr. de Lima discusses progress and remaining challenges with allogeneic CAR-T and other cellular therapy products.
Swaminathan Iyer, MDVideo Insights | September 14, 2023
Swaminathan Iyer, MD, joins Chadi Nabhan, MD, MBA, FACP, to discuss advances in T-cell lymphoma.
Chadi Nabhan, MD, MBA, FACPMyelodysplastic Syndromes | September 14, 2023
Joseph Khoury, MD; Sanam Loghavi, MD; and Chadi Nabhan, MD, MBA, FACP, discuss the MDS classification systems.
Chadi Nabhan, MD, MBA, FACPAggressive B-Cell Lymphoma | September 14, 2023
Jonathan Friedberg, MD, MMSc, discusses the trial and its implications for the field.
Chadi Nabhan, MD, MBA, FACPMeeting News | September 13, 2023
Dr. Garcia-Manero discusses key data from the phase III COMMANDS trial.
Rami Komrokji, MDAcute Myeloid Leukemia | September 12, 2023
The crew talk about AML and MDS in this episode of The HemOnc Pulse.
Chadi Nabhan, MD, MBA, FACPAcute Myeloid Leukemia | September 11, 2023
Dr. Erba answers this question and more in this interview with Dr. Chadi Nabhan.
Chadi Nabhan, MD, MBA, FACPMeeting News | September 10, 2023
Dr. Nath spoke transplant in patients with AML who are elderly and emphasized the need to include them in clinical trials.
Chadi Nabhan, MD, MBA, FACPMeeting News | September 8, 2023
Dr. Platzbecker joins Chadi Nabhan, MD, MBA, FACP, to discuss MDS at the Eleventh Annual Meeting of SOHO.
Marina Konopleva, MD, PhDMeeting News | September 8, 2023
Dr. Konopleva explains the controversy and what she sees on the horizon for MRD in AML.
Guillermo Garcia-Manero, MDMeeting News | September 7, 2023
Guillermo Garcia-Manero, MD, joins Chadi Nabhan, MD, MBA, FACP, to discuss the COMMANDS trial at the SOHO Annual Meeting.
Chadi Nabhan, MD, MBA, FACPChronic Lymphocytic Leukemia | August 24, 2023
Dr. Shadman rounds up the latest news on CLL from the summer conferences in this episode of The HemOnc Pulse.
Chadi Nabhan, MD, MBA, FACPAcute Myeloid Leukemia | August 10, 2023
The changes brought about by molecular characterization have a profound impact on real-world clinical care for AML.
Chadi Nabhan, MD, MBA, FACPChronic Lymphocytic Leukemia | July 27, 2023
Nitin Jain, MD, discusses the data on venetoclax combinations in CLL and key frontline treatment considerations.
Chadi Nabhan, MD, MBA, FACPThe HemOnc Pulse | July 13, 2023
Dr. Nowakowski discusses the L-MIND study and the "revolution in the treatment of DLBCL" in recent years.
Chadi Nabhan, MD, MBA, FACPAcute Myeloid Leukemia | June 29, 2023
Naveen Pemmaraju, MD, discusses the rare, ultrarare, and forgotten blood cancers on this episode of The HemOnc Pulse.